CytoDel Announces Pre-Clinical Data on Cyto-111 as Antidote to Botulinum Neurotoxin (BoNT) ...
Press release content from Globe Newswire. The AP news staff was not involved in its creation. CytoDel Announces Pre-Clinical Data on Cyto-111 as Antidote to Botulinum Neurotoxin (BoNT) ... CytoDel IncJanuary 7, 2021 GMT Studies Show Cyto-111 Enables Delivery of Antibodies to Previously Inaccessible Intraneuronal Targets without the need for a Viral Vector or Transfection Supports the Development of New Approaches to Treat Multiple Neurological Diseases NEW YORK, Jan. 07, 2021 (GLOBE NEWSWIRE) -- CytoDel, Inc. (“CytoDel” or “the Company”), a privately-held corporation, today announces...